STVN
Stevanato Group S.p.A.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STVN
this stock
Stevanato Group S.p.A.
|
$5.19B | -5.6% | — | — | 0.3% |
|
ISRG
Intuitive Surgical Inc
|
$150.88B | -24.8% | +20.5% | 51.8 | 2.2% |
|
MDLN
Medline Inc.
|
$119.55B | +2.8% | +11.5% | — | 2.1% |
|
BDX
Becton Dickinson & Co
|
$43.56B | +4.3% | +8.2% | — | 2.6% |
|
ALC
Alcon Inc
|
$33.97B | -11.6% | — | — | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STVN | +3.3% | +2.5% | -13.3% | +5.2% | -5.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +1.9% | +3.8% | -21.3% | +5.4% | -14.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.